Fredrik Bäckhed, one of the PIs at MIVAC was recently ranked as the number 12 super-talent in Sweden. The list was prepared by the news magazine "Veckans Affärer" and ranks young top achievers among all business and science categories. Congratulations Fredrik! See the list here.

Within a project entitled “Immunotherapy and the diagnosis of Alzheimer´s disease" MIVAC scientists in collaboration with MIVAC Development AB have developed a specific antibody against toxic components that cause Alzheimer´s disease. The verification grant will be used to verify the antibody´s active mechanism and to show proof of concept through a variety of studies. The end goal is to develop this antibody into both a drug and a diagnostic tool. 

“The verification grant will truly help us drive the project under a particularly value-enhancing commercial development phase and will also benefit the project´s scope for attracting continued financing, thus securing its future commercial development," says Anna Sjöblom-Hallén, project manager at MIVAC Development AB.

Click to read more about the Alzheimer's research findings.